Pain and Smoking Study - Interactive Voice Response
Launched by VA OFFICE OF RESEARCH AND DEVELOPMENT · May 29, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The Pain and Smoking Study (PASS2) is looking to help Veterans who smoke and also live with chronic pain. This study will use a method called Interactive Voice Response (IVR), which allows participants to receive support and guidance over the phone to help them quit smoking. By building on an earlier study, the goal is to make quitting smoking easier and more effective for those dealing with ongoing pain.
To be eligible for this study, you must be a Veteran enrolled at the VA Central Health System, currently using tobacco, and willing to try to quit smoking. You should also have significant chronic pain, rated at 4 or higher on a standard pain scale, for at least 90 days. Unfortunately, if you have certain conditions like severe hearing or speech issues, or if you are currently pregnant or have a serious mental health diagnosis, you may not be able to participate. If you join the study, you can expect to receive phone calls that will provide you with tools and support to help you quit smoking while managing your chronic pain.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • being an enrolled Veteran at VACHS;
- • current tobacco use;
- • willingness to make a quit attempt;
- • significant chronic pain defined as \>/=4 on the pain intensity portion of the Brief Pain Inventory (BPI) for more than 90 days.
- Exclusion Criteria:
- • active diagnosis of dementia or psychosis in medical record;
- • severely impaired hearing or speech;
- • lack of telephone access;
- • enrollment in concurrent research study that might affect main outcomes of this study;
- • terminal illness;
- • non-English speaking;
- • pregnancy;
- • provider advising against exercise;
- • planned surgeries; and
- • clinically significant depressive symptoms (\>10 PHQ-9).
About Va Office Of Research And Development
The VA Office of Research and Development (ORD) is dedicated to advancing the health and well-being of veterans through innovative research initiatives. As a pivotal sponsor of clinical trials, ORD focuses on a broad spectrum of health-related topics, including mental health, rehabilitation, and chronic disease management, ensuring that findings are directly applicable to the unique needs of the veteran population. With a commitment to scientific excellence and collaboration, ORD promotes rigorous study designs and ethical standards, facilitating the translation of research discoveries into improved clinical practices and policies that enhance veteran care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
West Haven, Connecticut, United States
Patients applied
Trial Officials
Lori Anne Bastian, MD MPH
Principal Investigator
VA Connecticut Healthcare System West Haven Campus, West Haven, CT
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported